Artwork

Content provided by CEimpact. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CEimpact or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Food Allergy and Anaphylaxis

35:40
 
Share
 

Manage episode 407078090 series 2931422
Content provided by CEimpact. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CEimpact or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The GameChanger
A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.

ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382

Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.

2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-079-H01-P
Initial release date: 03/18/2024
Expiration date: 03/18/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

  continue reading

274 episodes

Artwork
iconShare
 
Manage episode 407078090 series 2931422
Content provided by CEimpact. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CEimpact or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The GameChanger
A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.

ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382

Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.

2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-079-H01-P
Initial release date: 03/18/2024
Expiration date: 03/18/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

  continue reading

274 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide